// App-Quantinova.ai

P4-01-10 : Predictive impact of circulating tumor cells with an epithelial-to-mesenchymal transition phenotype in patients with primary breast cancer treated with primary systemic therapy

Researchers

Presenter

  • Le Du F

Principal Investigators

  • Duose DY

  • Dettman EJ

  • Ueno NTSummer JAChavez-MacGregor M

  • Barcenas CH

  • Brewster AM

  • Ricardo AH

  • Valero V

  • Gonzalez-Angulo AM

  • Reuben JM

Medical Centers

  • Centre Eugene-Marquis, Rennes, France

  • MD Anderson Cancer Center, University of Texas, Houston, TXApoCell, Inc, Houston, TX

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Cadherin 1

  • Circulating tumor cells

  • Cluster of Differentiation 24

  • Cluster of Differentiation 44

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved